Lv41
646 积分 2022-07-25 加入
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease
5小时前
已完结
Essential Thrombocythemia
2个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease
4个月前
已完结
Biolayer Interferometry: Protein–RNA Interactions
4个月前
已完结
皖公网安备34019202002308
